From taboo to transformative: the MedTech innovation that is changing lives

TAG'D: Beyond The Award

In this episode of TAG’D: Beyond the Award, host Justin Starbird sits down with Asaf Bar, CEO of Vibrant Gastro, to explore the innovation behind their FDA-cleared, drug-free vibrating capsule, a transformative bioelectronic solution for chronic constipation. Affecting more than 39 million Americans, chronic constipation often goes under-addressed due to stigma and a lack of effective treatments. Vibrant Gastro is changing that.

Their capsule stimulates the body’s natural peristalsis without the side effects commonly associated with pharmacological solutions. With over 800 patients enrolled in clinical trials and a post-market diarrhea rate of just 0.6%, the results speak for themselves. As the Top Innovator in Medical Devices for the 2025 TAG Awards for MedTech – Non-Pharmaceutical Therapeutics & Digital Health, Vibrant Gastro is not only helping patients reclaim their quality of life—it’s also paving the way for a scalable, software-driven platform that could treat multiple gastrointestinal conditions in the future.

🎧 Tune in to hear:

  • How Vibrant’s bioelectronic capsule works — and why it’s different

  • Why women in their 40s and 50s are the primary users

  • The company’s dual marketing strategy (direct-to-patient + prescribers)

  • What’s next for the platform, including expanded indications and reimbursement growth

🔗 Listen now and discover why Vibrant Gastro is being recognized as a true leader in MedTech innovation.